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Investigation into the Combined Affects of Tumor Necrosis Factor-Alpha, 
Tamoxifen and 5-Azacytidine on HTB-26 Breast Cancer Cells 
 
Gregory Roloff and Jessica Bosch 
Abstract 
 
 The primary goal of modern cancer therapeutic 
regiments is to develop treatments that are 
damaging to tumor cells but maintain the health of 
normal somatic cells. The “cocktails” of drugs used 
in current cancer treatment can interact in a 
mechanism that is not adequately understood. 
However, it is sometimes possible to use 
combinations of different chemicals to achieve the 
desired effect of killing the most cancer cells 
possible while preserving the patient’s other rapidly 
dividing cells. Our work to this point has been 
focused on two chemicals, sulforaphane (SFN), a 
organosulfur compound found in cruciferous 
vegetables, and Tumor Necrosis Factor-α (TNF), a 
cytokine involved in regulation of the immune 
response. The scope of our research is centered 
around apoptosis, or programmed cell death. In this 
project, we tested the effects of combining SFN 
treatment with varying amounts of TNF-α based on 
prior research from the O’Donnell lab showing the 
combination of SFN and TNF-α together cause 
apoptosis despite the fact that TNF-α alone is an 
insufficient inducing agent. In our preliminary 
experiments using cytotoxicity assays, we did find 
increased killing when the drugs were used in 
combination. Experiments using caspase 3 
apoptosis assays showed an increase in apoptosis 
with the combined treatment due to activation of 
the caspase 3 pathway. Moving forward, we have 
begun to investigate how altering gene regulation 
proteins might sensitize the cells to apoptosis 
induction via the use of 5-Azacytidine, a DNA 
methyltransferase inhibitor. 
 
Introduction 
 
The cell line we work with is HTB-26, derived 
from a 51 year old Caucasian female patient with 
breast cancer in 1979 (Cailleau). It can be described 
as an adenocarcinoma of the mammary gland that is 
derived from epithelial tissue. This cell line is 
tumorigenic in immunocompromised mice. One of 
the drugs we worked with is SFN, an 
isothiocyanate derived from broccoli and other 
cruciferous vegetables (Figure 1) (Jakubikova). 
Tumor necrosis factor α is a cytokine involved in 
inflammation. Recent research has shown that SFN 
and TNF-α may have synergistic effects when used 
together. Previous research has shown that TNF-α 
may activate NF-κB, an anti-apoptotic transcription 
factor (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Membrane domain of TNF pathway and 
chemical structure of sulforaphane 
 
Apoptosis is the process of programmed cell death 
and cancer cells often have mutations that prevent 
them from undergoing entering this process. TNF-α 
activates procaspase 8 which activates the 
executioner caspases, including caspase 3. 
Sulforaphane has also been shown to induce 
apoptosis through activation of reactive oxygen 
species-dependent caspase-3. This combination of 
drugs actually has a more lethal effect than either 
drug alone, leading to more apoptotic cells. 
Developing hypothesis look to test the levels of cell 
proliferation after first sensitizing the cells with 5-
Azacytidine, a methyltransferase inhibitor (Figure 
2.) 
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       Figure 2. Chemical structure of 5-Azacytidine. 
 
Materials 
 
Dulbecco’s PBS (Phosphate Buffered Saline), 
Trypsin, RPMI (Rochester Park Memorial 
Institute),  L-15 Medium (Leibovitz), L-15, FBS 
(Fetal Bovine Serum), Glutamax, TNF-α, SFN, 
Annexin V Kit (10x Binding Buffer, PI, Annexin, 
Distilled H20) , Caspase-3 Assay (Lysis Buffer, 2x 
Reaction Buffer 3, DTT, Caspase-3 calorimetric 
substrate), CyQuant Assay (CyQuant GR dye, Cell-
lysis buffer, DNA standard). MTT, isopropanol, 1N 
HCl. 
 
Methods 
 
Cyquant Assay : A 96 well plate was set up after 
cells were cultured and incubated. Each well 
received 100µL of media. SFN was kept constant in 
all wells through column 10. The bottom four rows 
received varying amounts of TNF. The plate was 
incubated at 370 C for 72 hrs and excess fluids were 
removed by flicking and blotting. A CyQuant assay 
was prepared, and added to each well and the 
fluorescence was measured. These experiments 
allowed us to verify the dosages to use in future 
experiments. 
 
Caspase 3 Assay: Cells were treated with nothing, 
SFN, tumor necrosis factor-α or a combination of 
drugs for 72 hours. Cells are collected by 
centrifugation at 250G for 10 minutes. The cells 
were lysed and then centrifuged. In a 96 well plate, 
50 µL of each sample was added to each well along 
with 50 µL of 2x Reaction Buffer 3 and 5 µL of 
Caspase-3 colorimetric substrate . The plate was 
incubated for 1-2 hours at 370 C and absorbance 
was read at 405 nm. 
 
MTT Assay: a 96 well plate was set up to measure 
cell proliferation.  Cells from the breast cancer line 
HTB-26 were exposed to SFN alone, SFN and 
various amounts of TNF, or nothing. The cells were 
incubated for 72 hours. MTT was prepared and 
20µL was added to each well and incubated for 5 
hours. The supernatant was removed and 100µL of 
a mixture composed of 9.6 mL isopropanol and 0.4 
mL HCl (1N) was added before the plate was read 
for fluorescence at 585 and 690 nm. 
 
Results 
 
Cytotoxicity experiments for HTB 26 cell lines 
revealed that the concentration of drug that showed 
the desired amount of killing was 0.035 mM, which 
ultimately came out to be 0.5mL of 0.28mM of 
SFN for every 4mLs of cells. The MTT cell 
proliferation assay detected an additional 7% 
killing in the presence of TNF, on top of the 57% 
caused by SFN alone. As the concentration of TNF 
increased, the amount of killing followed 
proportionally (figure 3). Results from the 
apoptosis assay, as depicted in figure 4, suggest that 
TNF and SFN may have a synergistic effect in 
inducing apoptosis, since the combination induced 
higher levels than the additive effects of the drugs 
alone. The CyQuant Assay illustrates that TNF 
alone is a poor killing agent, obtaining only a 6% 
increase from the cell control. However, TNF 
supplements the strong killing induced by SFN by 
an additional 6-7% (Figure 5). 
Figure 3. Graph depicting cell survival of HTB-26 
cells when incubated in uniform amounts of 
sulforaphane, while varying the amounts of TNF in 
the experimental rows. Different doses of TNF are 
distinguished by separate lines 
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Figure 4. Apoptosis Enrichment of HTB-26 cells 
based on all experimental treatments of SFN, TNF 
and a combination of both vs. a cell control that 
received no drug. 
Figure 5. Results from CyQuant Assay for cell 
survival of each experimental group. 
 
 
 
 
 
 
Discussion 
 
Overall data provides support for the notion that 
SFN causes cytotoxicity in HTB-26 cells and that a 
combination of TNF-α and SFN has a greater 
apoptosis inducing effect. This can have great 
clinical implications if it is able to kill cancer cells 
more effectively in vitro. However, treatment 
would have to be relatively safe to the body’s non-
cancerous cells, which divide at various rates. The 
new direction we are following is to determine 
whether 5-Azacytidine treatment will first weaken 
cells so they will be more sensitive to apoptosis 
induction with Sulforaphane and Tumor Necrosis 
Factor-α . Our further studies will examine the 
influence these experiments will have on MRC-5 
human fibroblasts (non-cancerous cells) and how 5-
Azacytidine might enhance previously obtained 
results. 
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